NCT03674788 The Prospective LEUVEN Transcatheter Valve Therapy Registry
| NCT ID | NCT03674788 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universitaire Ziekenhuizen KU Leuven |
| Condition | Heart Valve Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2008-03-12 |
| Primary Completion | 2037-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2008-03-12 with a primary completion date of 2037-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Assessment of feasibility, safety and outcomes of transcatheter valve interventions
Eligibility Criteria
Inclusion Criteria: * All patients selected for percutaneous treatment of a valve disorder potentially qualify for the present registry Exclusion Criteria: * All patients selected for percutaneous treatment of a valve disorder potentially qualify for the present registry. There are no formal exclusion criteria.
Contact & Investigator
Christophe Dubois, MD, PhD
✉ christophe.dubois@uzleuven.beFrequently Asked Questions
Who can join the NCT03674788 clinical trial?
This trial is open to participants of all sexes, studying Heart Valve Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03674788 currently recruiting?
Yes, NCT03674788 is actively recruiting participants. Contact the research team at christophe.dubois@uzleuven.be for enrollment information.
Where is the NCT03674788 trial being conducted?
This trial is being conducted at Leuven, Belgium.
Who is sponsoring the NCT03674788 clinical trial?
NCT03674788 is sponsored by Universitaire Ziekenhuizen KU Leuven. The trial plans to enroll 5,000 participants.